•• Du C, Berg WT, Siegal AR, Huang Z, Nguyen A, Cheung A, et al. A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third-line therapies? Neurourol Urodyn. 2021;40(1):391–6. New OAB patients follow-up and progress to third-line therapies faster and more frequently with the use of a CCP in an FPMRS-trained urologist practice. However, many OAB patients still fail to follow up and overall utilization of third-line therapies remains low. Future studies are warranted to identify factors to why overall OAB compliance remains low.

Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019;202(3):558–63.

Article  PubMed  Google Scholar 

•• Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438–43. This pivotal multicenter, double-blind, randomized, sham controlled trial provides level I evidence that percutaneous tibial nerve stimulation therapy is safe and effective in treating overactive bladder symptoms. The compelling efficacy of percutaneous tibial nerve stimulation demonstrated in this trial is consistent with other recently published reports and supports the use of peripheral neuromodulation therapy for overactive bladder.

Moossdorff-Steinhauser HFA, Berghmans B. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: A systematic review. Neurourol Urodyn. 2013;32(3):206–14.

Gaziev G, Topazio L, Iacovelli V, Asimakopoulos A, Di Santo A, De Nunzio C, et al. Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol. 2013;13(1):61.

Article  PubMed  PubMed Central  Google Scholar 

• Du C, Berg W, Siegal AR, Huang Z, Jeong R, Hwang K, et al. Real-world Compliance With Percutaneous Tibial Nerve Stimulation Maintenance Therapy in an American Population. Urology. 2021;153:119–23. Only 39.5% of patients continue to undergo maintenance PTNS therapy after 1 year. Future studies are required to understand and ameliorate factors for low compliance in PTNS maintenance therapy.

MacDiarmid S, Staskin DR, Lucente V, Kaaki B, English S, Gilling P, et al. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019;201(5):967–72.

Article  PubMed  Google Scholar 

Gilling P, Meffan P, Kaaki B, MacDiarmid S, Lucente V, Clark M, et al. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study. Urology. 2021;157:71–8.

Article  PubMed  Google Scholar 

Rogers A, Bragg S, Ferrante K, Thenuwara C, Peterson DKL. Pivotal Study of Leadless Tibial Nerve Stimulation with eCoin® for Urgency Urinary Incontinence: An Open-Label. Single Arm Trial J Urol. 2021;206(2):399–408.

PubMed  Google Scholar 

Kaaki B, English S, Gilling P, Meffan P, Lucente V, MacDiarmid S, et al. Six-Month Outcomes of Reimplantation of a Coin-Sized Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome With Urgency Urinary Incontinence. Female Pelvic Med Reconstr Surg. 2022;28(5):287–92.

Article  PubMed  PubMed Central  Google Scholar 

van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. J Urol. 2017;198(1):205–10.

Article  PubMed  Google Scholar 

Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints. Neurourol Urodyn. 2018;37(3):1060–7.

Article  PubMed  Google Scholar 

Dorsthorst MJT, Digesu GA, Tailor V, Gore M, van Kerrebroeck PE, van Breda HMK, et al. 3-Year Followup of a New Implantable Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome. J Urol. 2020;204(3):545–50.

Article  PubMed  Google Scholar 

te Dorsthorst M, Digesu A, van Kerrebroeck P, Elneil S, van Breda J, Janssen D, et al. Patient-tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms. Neurourol Urodyn. 2022;41(2):679–84.

Article  Google Scholar 

Sirls LT, Schonhoff A, Waldvogel A, Peters KM. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder - Sirls - 2023 - Neurourology and Urodynamics - Wiley Online Library [Internet]. [cited 2023 Mar 26]. https://onlinelibrary.wiley.com/doi/10.1002/nau.25117?af=R

Khaneshi M, Rahnama ’i Mohammad Sajjad, Ebrahimi SH. Mp32-17 effectivity of a novel implantable device (stimrouter) for the treatment of overactive bladder syndrome: 30 months results of a multi-centre study. J Urol. 2022;207(Supplement 5):e538.

Article  Google Scholar 

Keith Xavier, Dennis Miller, Kevin Benson, Kimberly Burgess, Janet Harris-Hicks, Robert Simon, et al. NM21 FEASIBILITY STUDY TO CHARACTERIZE THE IMPLANT PROCEDURE FOR A LEADLESS TIBIAL NERVE STIMULATOR, SUFU 2023 Conference. https://sufuorg.com/docs/meetings/sufu2303/abstracts.aspx. Accessed March 2023

Moskowitz D, Adelstein SA, Lucioni A, Lee UJ, Kobashi KC. Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers-Are We Doing Enough? J Urol. 2018;199(3):779–84.

Article  PubMed  Google Scholar